It is being tested to see if it reduces blood-clot risks. Aspirin, the common painkiller, is being tested as a potential treatment for patients hospitalized with the coronavirus…
Read MoreFood and Drug Administration
COVID Vaccine For All by Spring, Secretary Azar Says
Enough for the most vulnerable by year end. In an interview last week, Health and Human Services Secretary Alex Azar said all people in the U.S. could have…
Read More
FDA Officially Approves COVID Therapeutic
Remdesivir is the first officially approved treatment for COVID-19 in the U.S. Following new results published in the New England Journal of Medicine Thursday from Gilead Science’s Phase…
Read More
COVID Antibody Treatment Expected by Year-End
Government is acquiring doses as they are manufactured. Hundreds of thousands of doses of experimental antibody treatments for COVID-19 have already been secured by the U.S. government in…
Read More
Members of Congress Request Ban of Abortion Drug
Poses a ‘significant threat of danger’ to women’s health. Last week 20 Senators and 71 House Representatives requested that Food and Drug Administration Commissioner Stephen Hahn would classify…
Read More
CDC Alerts States to Prepare for November Vaccine Distribution
FDA has not yet approved a vaccine The Center for Disease Control (CDC) announced on Wednesday that states should begin ramping up infrastructure to distribute a vaccine for…
Read More
Safe Vaccine by Year End, Administration Predicts
Vaccine possible by Election Day, FDA chief says. A vaccine against the coronavirus is on the near horizon, government officials are saying. Dr. Anthony Fauci predicted there will…
Read More
FDA Changes Course on Plasma Treatment
Chief acknowledges overstating treatment effect. The Food and Drug Administration announced that it had gone too far in promoting the treatment effects of convalescent plasma in fighting against…
Read More
Convalescent Plasma for COVID-19 Approved by FDA
Operation Warp Speed credited with the accelerated timeline. President Trump announced during a press conference Sunday evening that the FDA has granted an emergency use authorization for convalescent…
Read More
FDA’s Plasma Program Data Lacks Cohesion
Informal study hampered by greater than anticipated participation of COVID-19 patients. The U.S. Food and Drug Administration designed a plasma program to try and speed along potential research…
Read More